A dressing configured to be positioned adjacent to a tissue site is disclosed herein. The dressing may include oxidized regenerated cellulose (ORC), collagen, and at least one nutrient including glutamine. Methods of treating a tissue site are also disclosed herein.

Embodiments disclosed herein are directed to the treatment of wounds using negative pressure. Some embodiments disclosed herein provide for a foam pad, which may be suitable for use in abdominal wound sites, and which may be sized in a dimensionally-independent manner. Additional embodiments provide for a wound contact layer, as well as a system for the treatment of abdominal wounds.

This disclosure includes wound dressings and systems with high-flow therapeutic gas sources for topical wound therapy and related methods. Some dressings, which are configured to be coupled to tissue to facilitate delivery of therapeutic gas to the tissue, comprise a manifold that defines a plurality of gas passageways, the manifold configured to allow communication of therapeutic gas to the tissue; and a gas-occlusive layer configured to be disposed over the manifold and coupled to the tissue such that an interior volume containing the manifold is defined between the gas-occlusive layer and the tissue and the gas- occlusive layer limits escape of therapeutic gas from the interior volume; wherein the gas- occlusive layer includes: a first opening configured to allow communication of therapeutic gas into the interior volume; and one or more second openings configured to allow communication of therapeutic gas out of the interior volume.

In some non-limiting examples, a system for stimulating tissue growth at a tissue site may include a porous foam and a moisture barrier. The porous foam may include an exterior-facing surface, a tissue contact surface, and a plurality of struts positioned at the tissue contact surface. The plurality of struts may be configured to contact the tissue site and to create tissue deformation at the tissue site without the application of a reduced pressure. The moisture barrier may be configured to cover the exterior-facing surface of the porous foam and to trap moisture at the tissue site. Also provided are other systems, apparatus, and methods suitable for stimulating tissue growth.

Dressings for tissue treatment, which may comprise a first layer and a second layer. The first layer may comprise or consist essentially of a first plurality of perforations formed through the first layer and arranged in a first pattern of rows. Each of the first plurality of perforations may be parallel to a first direction. The first layer may comprise or consist essentially of a second plurality of perforations formed through the second layer and arranged in a second pattern of rows. Each of the second plurality of perforations may be parallel to a second direction. The first plurality of perforations and the second plurality of perforations may be configured to open in response to a pressure gradient across the first layer. A second layer may comprise or consist essentially of a manifold, and coupled to the first layer.

A dressing configured to be positioned adjacent to a tissue site is disclosed herein. The dressing may include oxidized regenerated cellulose (ORC), collagen, and at least one nutrient including glutamine. Methods of treating a tissue site are also disclosed herein.

A long-term effective patch structure includes a binding layer, an absorbing layer and a water-proof layer sequentially stacked together. The binding layer has a function of attaching and fixing, and is configured to be attached and fixed on a skin. Sweat or liquid from the skin can pass through the binding layer to reach the absorbing layer, which is aligned with binding layer at the edge. The water-proof layer is water-proof and has vapor permeability, and its area is larger than the area of the absorbing layer. The outer part of the water-proof layer is attachable to the skin. Since the absorbing layer can absorb the liquid from the skin and the water-proof layer can ventilate the vapor to the outside, the skin is kept dry and comfortable and suitable to be attached to human skin for a long period of time without inducing skin allergy or discomfort.

A porous wound dressing for use in negative-pressure therapy is proposed. The wound dressing has an outer edge which defines a substantially oval or rectangular outer shape of the wound dressing with a major axis and a minor axis. The wound dressing has one or more incisions or perforations which together form one or more arc-shaped lines and serve for cutting the wound dressing to size in order to adapt the wound dressing to the shape and/or size of a wound. The one or more arc-shaped lines each extend asymmetrically with respect to the major axis and/or to the minor axis and each enclose, together with a portion of the outer edge, a segment of the wound dressing that is designed for separation from the wound dressing.

A wound treating article, system and kit, and methods of assembly and treating are provided where nanoporous isoporous membranes are pathogen tuned are combined with resilient, flexible or elastic supports to provide tailored wound treating bandages and/or kits for the medical industry.

A filter material for entrapping particles and actively affecting the trapped particles within the filter. The fabric has a blend of hydrophilic superabsorbent fibers and non-superabsorbent hydrophilic fibers that is sufficiently porous as to allow gaseous flow through the fabric. The fabric having a thickness and the fabric has as a coating of a mixture of a chemically or physically active compound and a liquid carrier forming an active composition on both the outer surface of the hydrophilic superabsorbent fibers, and the hydrophilic superabsorbent fibers have a central volume also retaining the active composition. The central volume of the hydrophilic superabsorbent fibers acting as a reservoir for replacement of the active compound into the coating when concentration of active compounds in the coating are reduced to a concentration less than concentrations of the active compound within the central volume; and the liquid carrier is an aqueous liquid.